Publication: Information needs of early-stage prostate cancer patients: A comparison of nine countries
| dc.contributor.authors | Feldman-Stewart, Deb; Capirci, Carlo; Brennenstuhl, Sarah; Tong, Christine; Abacioglu, Ufuk; Gawkowska-Suwinska, Marzena; van Gils, Francis; Heyda, Alicja; Igdem, Sefik; Macias, Victor; Grillo, Isabel Monteiro; Moynihan, Clare; Pijls-Johannesma, Madelon; Parker, Chris; Pimentel, Nuno; Woerdehoff, Herbert | |
| dc.date.accessioned | 2022-03-12T17:49:23Z | |
| dc.date.accessioned | 2026-01-11T08:00:25Z | |
| dc.date.available | 2022-03-12T17:49:23Z | |
| dc.date.issued | 2010 | |
| dc.description.abstract | Background and purpose: Providing information to patients can improve their medical and psychological outcomes. We sought to identify core information needs common to most early-stage prostate cancer patients in participating countries. Material and methods: Convenience samples of patients treated 3-24 months earlier were surveyed in Canada, England, Italy, Germany, Poland, Portugal, Netherlands, Spain, and Turkey. Each participant rated the importance of addressing each of 92 questions in the diagnosis-to-treatment decision interval (essential/desired/no opinion/avoid). Multivariate modelling determined the extent of variance accounted by covariates, and produced an unbiased prediction of the proportion of essential responses for each question. Results: Six hundred and fifty-nine patients responded (response rates 45-77%). On average, 35-53 questions were essential within each country; similar questions were essential to most patients in most countries. Beyond cross-country similarities, each country showed wide variability in the number and which questions were essential. Multivariate modelling showed an adjusted R-squared with predictors country, age, education, and treatment group of only 6% of the variance. A core of 20 questions were predicted to be essential to >2/3 of patients. Conclusions: Core information can be identified across countries. However, providing the core should only be a first step; each country should then provide information tailored to the needs of the individual patient. (C) 2010 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 94 (2010) 328-333 | |
| dc.identifier.doi | 10.1016/j.radonc.2009.12.038 | |
| dc.identifier.issn | 0167-8140 | |
| dc.identifier.pubmed | 20116122 | |
| dc.identifier.uri | https://hdl.handle.net/11424/230081 | |
| dc.identifier.wos | WOS:000276619500012 | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER IRELAND LTD | |
| dc.relation.ispartof | RADIOTHERAPY AND ONCOLOGY | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Early-stage prostate cancer | |
| dc.subject | Patient information needs | |
| dc.subject | Patient education | |
| dc.subject | DECISION-MAKING | |
| dc.subject | MEN | |
| dc.subject | RADIOTHERAPY | |
| dc.subject | SUPPORT | |
| dc.subject | CARE | |
| dc.subject | CHEMOTHERAPY | |
| dc.subject | TRIAL | |
| dc.subject | WANT | |
| dc.title | Information needs of early-stage prostate cancer patients: A comparison of nine countries | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 333 | |
| oaire.citation.issue | 3 | |
| oaire.citation.startPage | 328 | |
| oaire.citation.title | RADIOTHERAPY AND ONCOLOGY | |
| oaire.citation.volume | 94 |
